Subclinical hypercortisolism (SH) is a status of asymptomatic hypercortisolism, frequently found in patients with adrenal adenomas (estimated prevalence: 0.8-2% after 60 years of age). Although SH may lead to diabetes, hypertension and osteoporosis, the diagnostic SH criteria and those suggesting the need of adrenalectomy are debated. Indeed, beside the cortisol secretion, the individual cortisol sensitivity may play a role in determining the SH consequences. Subjects with possible SH due to adrenal adenoma will be randomized to surgery/conservative follow up. The effects of surgery on the cardiovascular, bone, metabolic complications of SH and on neuropsychological aspects and quality of life (QoL) and the possibility to predict them by using cortisol sensitivity and secretion markers will be studied. The study may clarify how to individuate patients who can benefit from surgery. These results will help reducing the costs of both useless surgical operations and SH consequences.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
variation of blood pressure
Timeframe: 6 months
variation of glucose levels
Timeframe: 6 months
variation of lipids
Timeframe: 6 months
variation of body weight
Timeframe: 6 months
variation of bone mineral density (BMD)
Timeframe: 24 months
occurrence of vertebral fractures
Timeframe: 24 months
variation of intimal medial thickness
Timeframe: 12 months
variation of Relative wall thickness (RWT)
Timeframe: 12 months
variation of Sheehan Disability Scale
Timeframe: 6 months
Cognitive evaluation by Brief Assessment Cognition in Schizophrenia (BACS) score
Timeframe: 6 months